483 related articles for article (PubMed ID: 22031815)
21. High-quality 3D structures shine light on antibacterial, anti-biofilm and antiviral activities of human cathelicidin LL-37 and its fragments.
Wang G; Mishra B; Epand RF; Epand RM
Biochim Biophys Acta; 2014 Sep; 1838(9):2160-72. PubMed ID: 24463069
[TBL] [Abstract][Full Text] [Related]
22. Antimicrobial peptides alter early immune response to influenza A virus infection in C57BL/6 mice.
LeMessurier KS; Lin Y; McCullers JA; Samarasinghe AE
Antiviral Res; 2016 Sep; 133():208-17. PubMed ID: 27531368
[TBL] [Abstract][Full Text] [Related]
23. Human Antimicrobial Peptides as Therapeutics for Viral Infections.
Ahmed A; Siman-Tov G; Hall G; Bhalla N; Narayanan A
Viruses; 2019 Aug; 11(8):. PubMed ID: 31374901
[TBL] [Abstract][Full Text] [Related]
24. Augmentation of innate host defense by expression of a cathelicidin antimicrobial peptide.
Bals R; Weiner DJ; Moscioni AD; Meegalla RL; Wilson JM
Infect Immun; 1999 Nov; 67(11):6084-9. PubMed ID: 10531270
[TBL] [Abstract][Full Text] [Related]
25. Effects of calcitriol (1, 25-dihydroxy-vitamin D3) on the inflammatory response induced by H9N2 influenza virus infection in human lung A549 epithelial cells and in mice.
Gui B; Chen Q; Hu C; Zhu C; He G
Virol J; 2017 Jan; 14(1):10. PubMed ID: 28114957
[TBL] [Abstract][Full Text] [Related]
26. A pharmacologically immunosuppressed mouse model for assessing influenza B virus pathogenicity and oseltamivir treatment.
Marathe BM; Mostafa HH; Vogel P; Pascua PNQ; Jones JC; Russell CJ; Webby RJ; Govorkova EA
Antiviral Res; 2017 Dec; 148():20-31. PubMed ID: 29100887
[TBL] [Abstract][Full Text] [Related]
27. Therapeutic Potential of Cathelicidin Peptide LL-37, an Antimicrobial Agent, in a Murine Sepsis Model.
Nagaoka I; Tamura H; Reich J
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825174
[TBL] [Abstract][Full Text] [Related]
28. Carbon Nanoparticles Inhibit the Antimicrobial Activities of the Human Cathelicidin LL-37 through Structural Alteration.
Findlay F; Pohl J; Svoboda P; Shakamuri P; McLean K; Inglis NF; Proudfoot L; Barlow PG
J Immunol; 2017 Oct; 199(7):2483-2490. PubMed ID: 28814602
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of zanamivir against avian influenza A viruses that possess genes encoding H5N1 internal proteins and are pathogenic in mammals.
Leneva IA; Goloubeva O; Fenton RJ; Tisdale M; Webster RG
Antimicrob Agents Chemother; 2001 Apr; 45(4):1216-24. PubMed ID: 11257037
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of the infectivity and inflammatory response of influenza virus by Arbidol hydrochloride in vitro and in vivo (mice and ferret).
Wang Y; Ding Y; Yang C; Li R; Du Q; Hao Y; Li Z; Jiang H; Zhao J; Chen Q; Yang Z; He Z
Biomed Pharmacother; 2017 Jul; 91():393-401. PubMed ID: 28475918
[TBL] [Abstract][Full Text] [Related]
31. Total alkaloids from Alstonia scholaris inhibit influenza a virus replication and lung immunopathology by regulating the innate immune response.
Zhou HX; Li RF; Wang YF; Shen LH; Cai LH; Weng YC; Zhang HR; Chen XX; Wu X; Chen RF; Jiang HM; Wang C; Yang M; Lu J; Luo XD; Jiang Z; Yang ZF
Phytomedicine; 2020 Oct; 77():153272. PubMed ID: 32702592
[TBL] [Abstract][Full Text] [Related]
32. Sequence determinants in the cathelicidin LL-37 that promote inflammation via presentation of RNA to scavenger receptors.
Kulkarni NN; O'Neill AM; Dokoshi T; Luo EWC; Wong GCL; Gallo RL
J Biol Chem; 2021 Jul; 297(1):100828. PubMed ID: 34048712
[TBL] [Abstract][Full Text] [Related]
33. LL-37: Cathelicidin-related antimicrobial peptide with pleiotropic activity.
Fabisiak A; Murawska N; Fichna J
Pharmacol Rep; 2016 Aug; 68(4):802-8. PubMed ID: 27117377
[TBL] [Abstract][Full Text] [Related]
34.
Lloren KKS; Kwon JJ; Choi WS; Jeong JH; Ahn SJ; Choi YK; Baek YH; Song MS
J Virol; 2019 Mar; 93(6):. PubMed ID: 30602610
[TBL] [Abstract][Full Text] [Related]
35. Quelling the storm: utilization of sphingosine-1-phosphate receptor signaling to ameliorate influenza virus-induced cytokine storm.
Walsh KB; Teijaro JR; Rosen H; Oldstone MB
Immunol Res; 2011 Oct; 51(1):15-25. PubMed ID: 21901448
[TBL] [Abstract][Full Text] [Related]
36. Comparison of Anti-Viral Activity of Frog Skin Anti-Microbial Peptides Temporin-Sha and [K³]SHa to LL-37 and Temporin-Tb against Herpes Simplex Virus Type 1.
Roy M; Lebeau L; Chessa C; Damour A; Ladram A; Oury B; Boutolleau D; Bodet C; Lévêque N
Viruses; 2019 Jan; 11(1):. PubMed ID: 30669255
[TBL] [Abstract][Full Text] [Related]
37. Anti-fungal activity of cathelicidins and their potential role in Candida albicans skin infection.
López-García B; Lee PH; Yamasaki K; Gallo RL
J Invest Dermatol; 2005 Jul; 125(1):108-15. PubMed ID: 15982310
[TBL] [Abstract][Full Text] [Related]
38. Inhibitory influence of the hexapeptidic sequence SLIGRL on influenza A virus infection in mice.
Betts RJ; Mann TS; Henry PJ
J Pharmacol Exp Ther; 2012 Dec; 343(3):725-35. PubMed ID: 22988062
[TBL] [Abstract][Full Text] [Related]
39. Mycophenolic mofetil, an alternative antiviral and immunomodulator for the highly pathogenic avian influenza H5N1 virus infection.
Cho J; Yi H; Jang EY; Lee MS; Lee JY; Kang C; Lee CH; Kim K
Biochem Biophys Res Commun; 2017 Dec; 494(1-2):298-304. PubMed ID: 29017920
[TBL] [Abstract][Full Text] [Related]
40. Structure-function relationships among human cathelicidin peptides: dissociation of antimicrobial properties from host immunostimulatory activities.
Braff MH; Hawkins MA; Di Nardo A; Lopez-Garcia B; Howell MD; Wong C; Lin K; Streib JE; Dorschner R; Leung DY; Gallo RL
J Immunol; 2005 Apr; 174(7):4271-8. PubMed ID: 15778390
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
